SEC sued for approving Nasdaq's 'racist, sexist' board rules

‘Woke, Inc.’ author: Corporations using ‘wokeness’ to avoid public scrutiny, regulations Entrepreneur and ‘Woke, Inc.’ author Vivek Ramaswamy discusses the rise of ‘wokeness’ in corporate America.   A conservative organization has filed a lawsuit against the U.S. Securities and Exchange Commission,…

Read More

U.S. Stocks Settle Notably Lower On Inflation Worries

U.S. stocks ended sharply lower on Monday, after languishing in negative territory right through the day’s session. High commodity prices, a surge in Treasury yields, worries about growth and rising inflation rendered the mood bearish. Traders were also worried that…

Read More

IPO Alert: Inhibikase Therapeutics (IKT)

Inhibikase Therapeutics is scheduled to make its debut on the Nasdaq Global Select Market today (December 23), under the ticker symbol “IKT.” Atlanta, Georgia-based Inhibikase Therapeutics is a clinical stage pharmaceutical company developing therapeutics kinase inhibitors for Parkinson’s disease and…

Read More

IPO Lockup Expiration Alert: Fusion Pharmaceuticals (FUSN)

The lockup period of Fusion Pharmaceuticals Inc. (FUSN) ends on December 23.. Canada-based Fusion Pharmaceuticals is a clinical-stage oncology company developing next-generation radiopharmaceuticals as precision medicines based on its proprietary platform called Targeted Alpha Therapies (TAT) together with its proprietary…

Read More